Baesi K - Search Results

1

Naturally occurring NS5A and NS5B resistant associated substitutions in HCV and HCV/HIV patients in iranian population.

Ramezani A, Baesi K, Banifazl M, Mohraz M, Khorvash F, Yaran M, Tabarsi P, Dalirrooyfard AH, Motevalli F, Bavand A, Aghakhani A. Ramezani A, et al. Among authors: baesi k. Clin Res Hepatol Gastroenterol. 2019 Oct;43(5):594-602. doi: 10.1016/j.clinre.2019.01.011. Epub 2019 May 10. Clin Res Hepatol Gastroenterol. 2019. PMID: 31080115

2

Antiretroviral drug resistance among antiretroviral-naïve and treatment experienced patients infected with HIV in Iran.

Baesi K, Ravanshad M, Ghanbarisafari M, Saberfar E, Seyedalinaghi S, Volk JE. Baesi K, et al. J Med Virol. 2014 Jul;86(7):1093-8. doi: 10.1002/jmv.23898. Epub 2014 Apr 17. J Med Virol. 2014. PMID: 24740443

3

Subtype classification of Iranian HIV-1 sequences registered in the HIV databases, 2006-2013.

Baesi K, Moallemi S, Farrokhi M, Alinaghi SA, Truong HM. Baesi K, et al. PLoS One. 2014 Sep 4;9(9):e105098. doi: 10.1371/journal.pone.0105098. eCollection 2014. PLoS One. 2014. PMID: 25188443 Free PMC article.

4

[Evaluation of miR-122 level in the plasma of chronically HCV infected patients].

Gholami M, Ravanshad M, Alavian SM, Baesi K, Moallemi S. Gholami M, et al. Among authors: baesi k. Mol Biol (Mosk). 2016 Mar-Apr;50(2):279-83. doi: 10.7868/S0026898416020075. Mol Biol (Mosk). 2016. PMID: 27239848 Free article. Russian.

5

HIV Drug Resistance and Phylogeny Profile in Naïve and Antiretroviral-Experienced Patients in Tehran, Iran.

Farrokhi M, Moallemi S, Baesi K, Ahsani-Nasab S, Gholami M, Sadeghi L, Mohraz M. Farrokhi M, et al. Among authors: baesi k. Intervirology. 2016;59(3):131-136. doi: 10.1159/000452712. Epub 2016 Dec 15. Intervirology. 2016. PMID: 27974715

6

Antiretroviral Drug Resistance Mutations among HIV Treatment Failure Patients in Tehran, Iran.

Farrokhi M, Moallemi S, Shirkoohi R, Golmohammadi R, Ahsani-Nasab S, Sardashti S, Abbasian L, Baesi K, Mohraz M. Farrokhi M, et al. Among authors: baesi k. Iran J Public Health. 2017 Sep;46(9):1256-1264. Iran J Public Health. 2017. PMID: 29026792 Free PMC article.

7

There is no Difference Between Sequences of HIV-1 Infected Patients with Stable Clinical Status and HIV-1 Reference Sequence.

Nili M, Tayeri K, Gholami M, Moallemi S, Sabahi F, Kalhori S, Baesi K, Hasibi M. Nili M, et al. Among authors: baesi k. Infect Disord Drug Targets. 2019;19(1):67-72. doi: 10.2174/1871526518666180222111611. Infect Disord Drug Targets. 2019. PMID: 29473526

8

Preparation and Evaluation of Ribonuclease-Resistant Viral HIV RNA Standards Based on Armored RNA Technology.

Gholami M, Ravanshad M, Baesi K, Samiee SM, Hosseini Rozbahani N, Mohraz M. Gholami M, et al. Among authors: baesi k. Iran Biomed J. 2018 Nov;22(6):394-400. doi: 10.29252/.22.6.394. Epub 2018 May 19. Iran Biomed J. 2018. PMID: 29776310 Free PMC article.

9

HIV drug resistance among naïve HIV-infected patients in Iran.

Farrokhi M, Gholami M, Mohraz M, McFarland W, Baesi K, Abbasian L. Farrokhi M, et al. Among authors: baesi k. J Res Med Sci. 2019 Apr 26;24:31. doi: 10.4103/jrms.JRMS_689_18. eCollection 2019. J Res Med Sci. 2019. PMID: 31143232 Free PMC article.

10

The Relationship Between HIV Antibody Titer, HIV Viral Load, HIV p24 Antigen, and CD4 T-cell Count Among Iranian HIV-positive Patients.

Moradbeigi M, SeyedAlinaghi S, Sajadipour M, Dadras O, Shojaei E, Ahmadi P, Bayanolhagh S, Baesi K, Rasoolinejad M. Moradbeigi M, et al. Among authors: baesi k. Infect Disord Drug Targets. 2020;20(5):752-757. doi: 10.2174/1871526519666191104144721. Infect Disord Drug Targets. 2020. PMID: 31682214

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

42 results

Search Page

Filters